SDHs were loaded with anticancer drug doxorubicin and tested for tumor-specific delivery, these were further modified with a unique aptamer known as MUC1, which have special recognition and binding affinity to the MUC1 glycoprotein which are generally overexpressed on the surface of many cancer cells. The gene discussed is MUC1; the disease is neoplasm.